The Billion-dollar Molecule
The Quest for the Perfect Drug
Simon & Schuster · Print & ebook · March 1, 1995
Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research.
We earn from qualifying purchases.
- Who it’s for
- Drug discovery meets startup ambition in a close-up of science, competition, and finance.
- Themes
- Pharmaceutical drug development, Biotech business and finance, AIDS drug research
- Pacing
- Fast
Nearest books
Matched by what the books are about, then ordered by what their readers also loved. Most of these share its genre: Pharma & Biotech Industry.
MoonshotDr. Albert Bourla58% match
The VaccineJoe Miller, Özlem Türeci56% match
The Panic VirusSeth Mnookin, Dan John Miller51% match
For younger readers: The Fight of Our Lives: AIDS in America, Mountains Beyond Mountains (adapted for Young People)
Start with three books, and this one can be the first.
Members get a new edition every morning: a route out from their books to essays, research and talks, with the reason for each.
Start with this bookAbout this book
Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing—atom by atom—both a new life-saving immunosuppressant drug, and a drug to combat the virus that causes AIDS.
Continue reading
You will be hooked from start to finish, as you go from the labs, where obsessive, fiercely competitive scientists struggle for a breakthrough, to Wall Street, where the wheeling and dealing takes on a life of its own, as Boger courts investors and finally decides to take Vertex public. Here is a fascinating no-holds-barred account of the business of science, which includes an updated epilogue about the most recent developments in the quest for a drug to cure AIDS.
Science Meets Finance
Drug discovery meets startup ambition in a close-up of science, competition, and finance.
Come here for
- The uneasy partnership between lab work and Wall Street
- A view into pharmaceutical research as both science and business
Expect
- Competitive scientists and investor dealmaking
- Drug research alongside the push to take a company public
Where it sits
| Pharma & Biotech Industry | 93% |
|---|---|
| Biotech | 27% |
| HIV & AIDS | 24% |
Percentages are BookFrontier’s reading of the book.
Publisher categories
- Business & Economics
- Pharma & Biotech Industry
- Molecular Modeling
- Authors
- Barry Werth
- Publisher
- Simon & Schuster
- Published
- March 1, 1995
- Format
- Print & ebook
- Theme
- Pharmaceutical drug development · Biotech business and finance · AIDS drug research
- Reading lane
- Business & Economics